Latest Share Chat

REMOVE ADS

Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

1,900.00 -13.00 (-0.68%)

Bid:

1,901.00

Ask:

1,902.00

Spread: 1.00 (0.053%)

Market Cap: £76.20b

Last checked at -

Intraday Glaxosmithkline Share Chart

REMOVE ADS

Glaxosmithkline News

LONDON MARKET CLOSE: FTSE 100 ends winning run ahead of Fed rate call

(Alliance News) - The FTSE 100 ended a 16-day winning streak on Wednesday, ahead of interest rate decisions in the US and UK, weighed by weak pharmace...

London close: FTSE snaps 16-day win streak ahead of Fed

(Sharecast News) - London stocks ended lower on Wednesday, with the top-flight index snapping a 16-day winning streak as investor caution ahead of the...

LONDON MARKET MIDDAY: Stocks decline before central bank decisions

(Alliance News) - Stock prices in London were weaker on Wednesday, with some pre-Federal Reserve decision nerves and geopolitical tensions hurting sen...

GSK, AstraZeneca slide after FDA unveils new vaccine lead

(Sharecast News) - Shares in GSK and AstraZeneca came under pressure on Wednesday, after vaccine-sceptic Vinay Prasad was appointed to a key role at t...

LONDON BROKER RATINGS: Deutsche Bank cuts BT Group and Deliveroo

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

LONDON MARKET OPEN: European shares struggle despite US-China hope

(Alliance News) - London's FTSE 100 gave back a fraction of its recent progress early Wednesday, despite some optimism on the tariff front, ahead of a...

LONDON MARKET CLOSE: FTSE 100 stutters despite fresh tech-led US gains

(Alliance News) - The FTSE 100 edged higher on Thursday, extending its best winning run since 2017, supported by tech-inspired gains on Wall Street.

GSK's Nucala delivers positive outcomes in published trial results

(Sharecast News) - GSK announced on Thursday that its monoclonal antibody 'Nucala', or mepolizumab, delivered a statistically significant and clinical...